Nanotherapy for Pancreatitis: From Single-Cell Targeting Toward Multicellular-Coordinated Regulation

Bi Fei Li1, Xing Hui Li1, Yan Deng1

  • 1Medical Imaging Key Laboratory of Sichuan Province, Department of Radiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, People's Republic of China.

Insights

This review explores how targeting specific cells with nanotechnology offers new hope for treating pancreatitis. It bridges understanding of disease mechanisms with nanomedicine design for better therapies.

Area of Science:

  • Gastroenterology and Hepatology
  • Nanomedicine
  • Cellular Biology

Background:

  • Pancreatitis is a global health issue with complex cellular causes and few treatment options.
  • Nanotechnology-based therapies show promise but require better understanding of cellular targets and mechanisms.
  • Current knowledge on cellular pathogenesis and nanotherapeutic strategies for pancreatitis is fragmented.

Purpose of the Study:

  • To review recent advances in understanding pancreatitis pathogenesis from a cellular perspective.
  • To analyze nanotechnology-based approaches targeting specific cells involved in pancreatitis.
  • To provide a framework for developing coordinated nanomedicines for pancreatitis.

Main Methods:

  • Literature review of cellular pathogenic mechanisms in pancreatitis.
  • Analysis of nanotechnology-based therapeutic strategies targeting these cells.
  • Synthesis of information to bridge cellular pathogenesis and nanotherapeutic design.

Main Results:

  • Detailed examination of various cell populations contributing to pancreatitis.
  • In-depth analysis of nanotechnology-based approaches for cell-targeted therapy.
  • Identification of gaps in understanding nanotherapeutic mechanisms and multicellular coordination.

Conclusions:

  • A clear framework for cell-targeted nanotherapeutics in pancreatitis is proposed.
  • Insights into pathological and methodological aspects are provided.
  • Future development of multicellular-coordinated nanomedicines for pancreatitis is guided.